67 related articles for article (PubMed ID: 20971100)
21. Formation of reactive intermediates by phase II enzymes: glutathione-dependent bioactivation reactions.
Vamvakas S; Anders MW
Adv Exp Med Biol; 1991; 283():13-24. PubMed ID: 2068979
[No Abstract] [Full Text] [Related]
22. [Mechanisms of bioactivation of xenobiotics under the influence of enzymatic systems of the body].
Zholdakova ZI; Kharchevnikova NV
Vestn Ross Akad Med Nauk; 2002; (8):44-9. PubMed ID: 12212380
[No Abstract] [Full Text] [Related]
23. Bioactivation of xenobiotics by flavin-containing monooxygenases.
Ziegler DM
Adv Exp Med Biol; 1991; 283():41-50. PubMed ID: 2069015
[No Abstract] [Full Text] [Related]
24. A labeled substrate approach to discovery of biocatalytic reactions: a proof of concept transformation with N-methylindole.
Rogers JL; MacMillan JB
J Am Chem Soc; 2012 Aug; 134(30):12378-81. PubMed ID: 22809085
[TBL] [Abstract][Full Text] [Related]
25. Effect of decanoic acid and 10-hydroxydecanoic acid on the biotransformation of methyl decanoate to sebacic acid.
Sugiharto YEC; Lee H; Fitriana AD; Lee H; Jeon W; Park K; Ahn J; Lee H
AMB Express; 2018 May; 8(1):75. PubMed ID: 29730843
[TBL] [Abstract][Full Text] [Related]
26. Biological activity of new bioactive steroids deriving from biotransformation of cortisone.
Costa S; Tedeschi P; Ferraro L; Beggiato S; Grandini A; Manfredini S; Buzzi R; Sacchetti G; Valacchi G
Microb Cell Fact; 2022 Nov; 21(1):250. PubMed ID: 36419154
[TBL] [Abstract][Full Text] [Related]
27. Historical perspectives on conjugation-dependent bioactivation of foreign compounds.
Miller JA; Surh YJ
Adv Pharmacol; 1994; 27():1-16. PubMed ID: 8068550
[No Abstract] [Full Text] [Related]
28. Biotransformation and bioactivation reactions - 2016 literature highlights.
Khojasteh SC; Rietjens IMCM; Dalvie D; Miller G
Drug Metab Rev; 2017 Aug; 49(3):285-317. PubMed ID: 28468514
[TBL] [Abstract][Full Text] [Related]
29. Novel advances in biotransformation and bioactivation research - 2020 year in review.
Khojasteh SC; Argikar UA; Driscoll JP; Heck CJS; King L; Jackson KD; Jian W; Kalgutkar AS; Miller GP; Kramlinger V; Rietjens IMCM; Teitelbaum AM; Wang K; Wei C
Drug Metab Rev; 2021 Aug; 53(3):384-433. PubMed ID: 33910427
[TBL] [Abstract][Full Text] [Related]
30. Biotransformation and bioactivation reactions - 2018 literature highlights.
Khojasteh SC; Bumpus NN; Driscoll JP; Miller GP; Mitra K; Rietjens IMCM; Zhang D
Drug Metab Rev; 2019 May; 51(2):121-161. PubMed ID: 31170851
[TBL] [Abstract][Full Text] [Related]
31. Editorial overview: biocatalysis and biotransformation: riding the third wave of biocatalysis.
Moore JC; Bornscheuer UT
Curr Opin Chem Biol; 2014 Apr; 19():v-vi. PubMed ID: 24704005
[No Abstract] [Full Text] [Related]
32. Targeting Mitochondria in Age-Related Vascular Changes: A New Arrow to the Bow of Antioxidant Treatment?
Masi S; Virdis A
Hypertension; 2018 Jun; 71(6):1023-1025. PubMed ID: 29661839
[No Abstract] [Full Text] [Related]
33. Unraveling the Antioxidant Activity of
Xu Y; Li Z; Wang Y; Li C; Zhang M; Chen H; Chen W; Zhong Q; Pei J; Chen W; Haenen GRMM; Moalin M
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762525
[TBL] [Abstract][Full Text] [Related]
34. Carcinostatic effects of alkanoyl ascorbate plus platinum nano-colloid and stabilization of the esterolytically resultant ascorbate by hydrogen.
Kato S; Saitoh Y; Miwa N
Hum Cell; 2021 Mar; 34(2):436-444. PubMed ID: 33387361
[TBL] [Abstract][Full Text] [Related]
35. Molecular strategies for targeting antioxidants to mitochondria: therapeutic implications.
Apostolova N; Victor VM
Antioxid Redox Signal; 2015 Mar; 22(8):686-729. PubMed ID: 25546574
[TBL] [Abstract][Full Text] [Related]
36. Mitochondrial dysfunction and biogenesis: do ICU patients die from mitochondrial failure?
Kozlov AV; Bahrami S; Calzia E; Dungel P; Gille L; Kuznetsov AV; Troppmair J
Ann Intensive Care; 2011 Sep; 1(1):41. PubMed ID: 21942988
[TBL] [Abstract][Full Text] [Related]
37. Putting bioactivation reactions to work: Targeting antioxidants to mitochondria.
Anders MW
Chem Biol Interact; 2011 Jun; 192(1-2):8-13. PubMed ID: 20971100
[TBL] [Abstract][Full Text] [Related]
38. Mitochondrial biotransformation of omega-(phenoxy)alkanoic acids, 3-(phenoxy)acrylic acids, and omega-(1-methyl-1H-imidazol-2-ylthio)alkanoic acids: a prodrug strategy for targeting cytoprotective antioxidants to mitochondria.
Roser KS; Brookes PS; Wojtovich AP; Olson LP; Shojaie J; Parton RL; Anders MW
Bioorg Med Chem; 2010 Feb; 18(4):1441-8. PubMed ID: 20129794
[TBL] [Abstract][Full Text] [Related]
39. Exploiting endobiotic metabolic pathways to target xenobiotic antioxidants to mitochondria.
Anders MW
Mitochondrion; 2013 Sep; 13(5):454-63. PubMed ID: 23123918
[TBL] [Abstract][Full Text] [Related]
40. Medium-chain acyl-CoA dehydrogenase- and enoyl-CoA hydratase-dependent bioactivation of 5,6-dichloro-4-thia-5-hexenoyl-CoA.
Fitzsimmons ME; Thorpe C; Anders MW
Biochemistry; 1995 Apr; 34(13):4276-86. PubMed ID: 7703241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
